How Biosimilars Dismantle Biologic Monopolies: The Definitive IP, Pricing, and Lifecycle Strategy Guide
For pharma IP teams, portfolio managers, R&D leads, and institutional investors tracking the $72B biosimilar market. 1. Executive Summary and […]
Biosimilar Supply Chain: How to Turn Its Biggest Weaknesses Into Your Competitive Edge
The U.S. healthcare system has already saved an estimated $23.6 billion from biosimilar use [1]. Yet for all that money
Biosimilar Supply Chain: How to Turn Its Biggest Weaknesses Into Your Competitive Edge Read Post »
FTO Analysis in Generic Drug Development: The Complete IP and Stability Testing Playbook
Generic drug development sits at the intersection of two disciplines that most organizations still treat as separate workstreams: intellectual property
FTO Analysis in Generic Drug Development: The Complete IP and Stability Testing Playbook Read Post »
The Pharma Patent Playbook: How to Build, Defend, and Monetize Drug IP That Actually Holds
A $2.23 billion bet on a molecule. A 90% chance it never reaches a patient. A 20-year patent clock that
The KSM Playbook: How Key Starting Material Decisions Shape Drug Programs, IP Portfolios, and Market Share
Introduction: The Decision That Happens Before Anyone Is Watching The pharmaceutical industry runs on headline milestones. The Phase III readout.
The Definitive Biopharmaceutical Freedom-to-Operate Playbook: From Scoping to Execution, Patent Thickets to Platform IP
Part I: The Strategic and Financial Imperative of FTO The $2.6 Billion Bet and the One Analysis That Protects It
Pharmaceutical Drug Naming: The Complete IP, Patent, and Brand Strategy Guide
1. Why Drug Naming Is an IP Function, Not a Marketing Task The name on the bottle is not chosen
Pharmaceutical Drug Naming: The Complete IP, Patent, and Brand Strategy Guide Read Post »
Google Patents for Drug Patent Research: The Definitive Analyst’s Playbook
Part I: The Economic Architecture of Pharmaceutical Intellectual Property 1.1 The Patent Bargain and Its Financial Consequences The pharmaceutical industry
Google Patents for Drug Patent Research: The Definitive Analyst’s Playbook Read Post »
Drug Patent Protection in Global Markets: The Strategic Playbook
For pharma IP teams, portfolio managers, R&D leads, and institutional investors who need a complete, jurisdiction-by-jurisdiction framework — not another
Drug Patent Protection in Global Markets: The Strategic Playbook Read Post »
